StockData
Adaptimmune Therapeutics PLC logo

Adaptimmune Therapeutics PLC (ADAPY) stock

ADAPYOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2025, quý kết thúc ngày Jun 30, 2025Last filing: 10-Q on Aug 13, 2025Score 3/30
$0.04+0.00 (+9.38%)

Close on Oct 19, 2026Market cap $55.46MP/E –Yield –

Adaptimmune Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Adaptimmune Therapeutics's price to book ratio was 35.9× on Apr 30, 2025, against 41.0× a year earlier. Over the last 5 years it ranged from 5.8× to 83.6×, with a median of 14.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 202535.9×+25.6
2024Dec 31, 202410.3×−1.9
2023Dec 29, 202312.3×−0.4
2022Dec 30, 202212.7×−1.9
2021Dec 31, 202114.6×+1.3
2020Dec 31, 202013.3×+8.2
2019Dec 31, 20195.1×−30.1
2018Apr 30, 201835.2×+18.8
2017Dec 29, 201716.4×+9.8
2016Dec 30, 20166.6×−13.1
2015Dec 31, 201519.8×–

More Adaptimmune Therapeutics figures

See a number that looks wrong?